Int6/eIF3-p48 was ®rst identi®ed as a common integration site for MMTV in mouse mammary tumors. In all cases, the MMTV integration event resulted in an interruption of the normal Int6 transcript from one allele leaving the second allele intact and operative. We hypothesize that insertion of MMTV into Int6 results in a mutated allele that encodes a shortened Int6 mRNA and protein (Int6sh), which either modi®es normal Int6 function or possesses a new independent function. To con®rm the transforming potential of the mutation and its dominant function, we transfected two mammary epithelial cell lines, MCF10A (human), and HC11 (mouse), with Int6sh under the control of the elongation factor-1a (eEF1A) promoter. Expression of Int6sh in MCF10A and HC11 mammary epithelial cells leads to anchorage-independent growth in soft agar indicative of a transformed phenotype. Colonies selected from agar exhibited high levels of mutated Int6sh and wild type Int6 RNA transcripts by RT ± PCR and Northern blot analysis. In addition, Int6sh transformed MCF10A and HC11 cells formed nodular growths, in vivo, in immune compromised hosts. NIH3T3 cells, mouse embryo ®broblasts, were also transformed to anchorage-independent growth in vitro by Int6sh expression. These observations provide direct evidence that the Int6 mutations observed in MMTV-induced tumors and hyperplasia contribute to the malignant transformation of the mammary epithelial cells. Oncogene (2001) 20, 5291 ± 5301.
Int6/eIF3-p48 was ®rst identi®ed as a common integration site for MMTV in mouse mammary tumors. In all cases, the MMTV integration event resulted in an interruption of the normal Int6 transcript from one allele leaving the second allele intact and operative. We hypothesize that insertion of MMTV into Int6 results in a mutated allele that encodes a shortened Int6 mRNA and protein (Int6sh), which either modi®es normal Int6 function or possesses a new independent function. To con®rm the transforming potential of the mutation and its dominant function, we transfected two mammary epithelial cell lines, MCF10A (human), and HC11 (mouse), with Int6sh under the control of the elongation factor-1a (eEF1A) promoter. Expression of Int6sh in MCF10A and HC11 mammary epithelial cells leads to anchorage-independent growth in soft agar indicative of a transformed phenotype. Colonies selected from agar exhibited high levels of mutated Int6sh and wild type Int6 RNA transcripts by RT ± PCR and Northern blot analysis. In addition, Int6sh transformed MCF10A and HC11 cells formed nodular growths, in vivo, in immune compromised hosts. NIH3T3 cells, mouse embryo ®broblasts, were also transformed to anchorage-independent growth in vitro by Int6sh expression. TheseIntroduction Int6 was identi®ed and cloned from an MMTVinduced premalignant Czech II mouse mammary epithelial outgrowth line, CZZ1, and its subsequent tumors and metastases, as well as in two additional independent tumors found in the mammary glands of MMTV-infected Czech II mice . All Int6 mutations resulted from insertion of full length MMTV DNA, within intron 5 or intron 9 of the Int6 gene, in the opposite transcriptional orientation. This insertional event resulted in transcription of a truncated Int6 mRNA (Int6sh) in all three independent tumors due to a cryptic transcription stop sequence within the U3 portion of the MMTV ± LTR.
Recently, Int6 was discovered to be the gene encoding the eukaryotic translation initiation factor 3 (eIF3) p48 subunit (Asano et al., 1997a) . Mammalian eIF3 is a complex comprised of at least 10 subunits and plays an integral part in translation initiation. The eIF3 complex is involved in at least three crucial aspects of translation initiation. The ®rst is the dissociation of the 80S ribosomal complex and recruitment of the ternary complex (eIF2-GTP-MettRNA) (Hershey, 1991) . Second, in association with the eIF4F complex, it is responsible for the binding and alignment of mRNA (Methot et al., 1996; Pestova et al., 1996) . Lastly, it appears to regulate the recruitment of eIF5 to the 40S pre-initiation complex (Asano et al., 1999) . However, little is known about the manner in which each of the 10 eIF3 subunits interact and bind with each other or to other translation initiation proteins (Asano et al., 1997b) .
Transforming or oncogenic properties of translation initiation components have been previously documented. Overexpression of translation initiation factors eIF-4E and eIF4G alone has been shown to transform NIH3T3 cells in vitro. Subsequently, rat embryo ®broblasts were also transformed in collaboration with v-myc or E1A (Fukuchi-Shimogori et al., 1997; Lazaris-Karatzas et al., 1990; Lazaris-Karatzas and Sonenberg, 1992) . Both eIF3 subunits p40 and p48 are required for binding to the 40S translation preinitiation complex in eukaryotic cells, however whether these two translation initiation factors directly interact with one another is unknown. Ampli®cation and mRNA overexpression of the eIF3p40 gene is associated with breast and prostate cancer (Nupponen et al., 1999) . Nupponen et al. (2000) eIF3-p40 to chromosome 8q23-24, relatively close to Int6/eIF3-p48, which lies at 8q22-23. Recurrent genetic aberrations have been detected in chromosome regions 8q21 and 8q23-24 and are linked to breast and prostate cancer. The chromosomal localization of eIF3 subunits p40 and p48 near one another as well as their potential involvement in breast cancer may be of signi®cance.
In the present work, we demonstrate that expression of a truncated Int6 gene (Int6sh), in the presence of two fully competent copies of wild type Int6 gene, is sucient to transform the growth properties of both mammary epithelial cells and NIH3T3 cells in vitro.
Results
Human (MCF10A) and mouse (HC11) mammary epithelial cell lines were utilized as target cells for assessing the eects of Int6sh expression on anchoragedependent and anchorage-independent growth in vitro. Transplantation of the Int6sh transfected cell lines into murine host mammary fat pads was used to ascertain whether the Int6sh-transformed cells were capable of producing either hyperplastic or malignant epithelial outgrowths in mice.
The Int6sh RNA transcript is 660 bp long as compared to 1.5 kb full length Int6 transcript ( Figure  1) . A truncated form of Int6 was selected because the MMTV-induced mutations found in three independent tumors expressed a shortened Int6 RNA transcript. A severely truncated form of the Int6 message was also selected because it represented the shortest of all the truncations caused by MMTV DNA insertion within introns of the Int6 gene in these tumors and was therefore considered the most likely to produce an independent phenotype.
To determine whether our Int6sh and Int6 wild type expression constructs were capable of producing the predicted protein products in vitro, they were tested in Promega's TnT TM T7 coupled in vitro transcription/ translation system using both reticulocyte or wheat germ lysates. In each of these systems appreciable levels of Int6 wild type (52 kDa) and truncated Int6 (14 kDa) protein were produced. Premature translation termination was ruled out as the hemagluttinin (HA) tag at the C-terminus of the Int6 wild type and truncated Int6 protein was precipitated with both monoclonal and polyclonal HA antibodies. An identical size product was identi®ed as well by an antibody raised against an Int6 speci®c peptide representing an N-terminal domain common to both Int6sh and Int6 wild type (Figure 2 ). This demonstrated that the Figure 1 Int6 short transfection vector and motifs. To express truncated Int6, a vector was constructed from the pCDNA 3.1(+) backbone, replacing the cytomegalovirus (CMV) promoter with elongation factor 1-alpha (eEF1A) promoter and adding a hemagluttinin (HA) epitope tag for protein identi®cation purposes. (a) Int6sh-pCEFLHA vector. (b) Int6 localization motifs. Int6/ eIF3-p48 contains two cellular localization signals, a bipartite nuclear localization signal and a nuclear export signal (NES) (Guo and Sen, 2000) . The nuclear localization signal is located towards the C-terminus (amino acids 264 ± 445) of Int6/eIF3-p48 while the NES is located near the amino terminus (leucines 6, 14 and 18). The Proteasome-COP9 complex Initiation (PCI) and ProteasomeInt6-Nip1-Trip15 (PINT) motifs are located at amino acids 328 ± 407 and 328 ± 391 respectively. The epitope of antibody #47 (Int6 #47) is located at the N-terminus of Int6 (amino acids 58 ± 73) while antibody #20's epitope is found near the center of the Int6 protein (amino acids 265 ± 284). Thus, Int6 #20 antibody does not recognize the Int6sh protein (amino acids 1 ± 137) constructs produced the predicted full-length Int6sh and Int6 wild type proteins. Using equal amounts of both constructs in the in vitro translation reaction, we found that both constructs can be translated simultaneously (data not shown), thus, one message does not preclude the other being translated in vitro. Both reticulocyte and wheat germ lysates produced similar results. This was important because Int6 has been reported to be a member of the eIF3 translation complex and we wished to rule out any interference with Int6sh mRNA translation initiation.
In vitro transformation of mammary cell lines
The amino acid sequence of human and mouse Int6 proteins are identical (Miyazaki et al., , 1997 . Therefore, the human mammary epithelial cell line, MCF10A, and mouse mammary epithelial cell line, HC11, were chosen as targets because these cells are of mammary origin and exhibit anchorage dependent growth properties in vitro and are non-tumorigenic in vivo. Stable cell lines expressing Int6sh and Int6 wild type were generated by transfection of the Int6sh/ pCEFLHA or Int6 wild type/pCEFLHA constructs using standard liposomal reagents into MCF10A, HC11 or NIH3T3 cells followed by neomycin selection. All of these cell lines produced stable populations that were positive for expression of the full-length mRNA when tested by RT ± PCR or Northern blot (not shown). To ascertain whether overexpression of the Int6sh gene would aect the growth properties of MCF10A, HC11 and NIH3T3 cells, soft agar growth assays were performed (MacPherson and Montagnier, 1964) . Cells were seeded into soft agar and allowed to grow for 6 weeks. Harvey Ras-transformed MCF10A cells (MCF10AneoT), which have been shown to form colonies in soft agar (a kind gift from Dr David Salomon, LTIB, NCI, USA), were used as a positive control for growth in soft agar (Ciardiello et al., 1990a (Ciardiello et al., 1992 Normanno et al., 1994) . Int6sh transfected MCF10A cells produced a larger number of colonies compared with MCF10A cells and were found to be equivalent in colony-forming ability with the Harvey Ras-transformed MCF10A cells (MCF10AneoT) (see Figure 5 ). In separate growth rate studies on plastic, a slight increase in the proliferation rate was observed for the Int6sh-transformed MCF10A cell line as compared to the MCF10A cells (data not shown). The largest colonies in soft agar were isolated and analysed for Int6sh expression by RT ± PCR and Northern blot analysis. A high level of the Int6sh transcript was detected in all clones chosen by soft agar growth capability indicating a strong correlation between the acquisition of anchorage independent growth and Int6sh expression (not shown Similar results were obtained when we transfected Int6sh into either HC11, mouse mammary epithelial cells or NIH3T3 ®broblasts. A high level of Int6sh transcript was detectable in the stable transfectants by both RT ± PCR and Northern blot analysis (data not shown) and the Int6sh transfected HC11 cells exhibited a signi®cant ability to form colonies in soft agar compared to HC11 cells alone ( Figure 5 ). To determine whether truncated Int6sh-transforming capacity was eective in non-epithelial cell cultures, we transfected NIH3T3 mouse embryo ®broblasts. Int6sh-transfected NIH3T3 cells grew slightly faster than non-transfected cells on plastic (data not shown) and exhibited anchorage independent growth in soft agar ( Figure  5 ). Doubly-transformed DBL/NIH3T3 (DBL, clone 1, K-Ras, SV40T-transformed NIH3T3) cells were pro-vided by Dr David Salomon, LTIB, NCI as a positive control for anchorage independent growth of 3T3 cells in soft agar (Ciardiello et al., 1990b) . Anchorage independent growth of the transformed NIH3T3 cells was also associated with high levels of Int6sh mRNA expression. Thus the correlation between anchorage independent growth and high levels of Int6sh RNA expression obtained in mammary epithelial cells extends to NIH3T3 ®broblast cells.
Growth of Int6sh-transfectants in vivo
To assess their tumorigenic potential, Int6sh transfected cell lines were transplanted into athymic (nu/nu) mice (Tables 1 and 2 ). A total of three in vivo experiments were done using the Int6sh/MCF10A cell lines with a minimum duration of 3 months (Table 1 ). In the ®rst experiment, transplants of 2610 6 cells/ injection were injected into the scapular fat pad with Matrigel. The appearance of one nodule containing Int6sh transfected MCF10A cells was detected after 3 months. This epithelial nodule was sectioned at 50 mm step intervals and mounted onto slides. The intervening sections were pooled for DNA extraction and PCR analysis for the presence of human Alu sequences within the epithelial nodule. Alu sequences were found and con®rmed that the epithelial nodule was of human and not of mouse origin ( Figure 6 ) (Jurka and Milosavljevic, 1991) . In the second experiment, transplants of 2610 6 cells/bolus were injected subcutaneously near the inguinal mammary fat pads. These inoculations did not yield any epithelial nodules in either MCF10A cells or Int6sh transfected MCF10A cells (Table 1 ). In the third experiment, a 56larger number of transformed and control cells (1610 7 cells) was inoculated subcutaneously within the inguinal mammary gland. Epithelial nodules were detected in seven out 15 transplants (47%) ( Table 1) . Implantation of 5 mg diethylstilbestrol pellets (20% diethylstibestrol/ 80% cholesterol) to increase the level of estrogenic stimulation of mammary epithelial growth over the duration of transplantation had no discernible eect on the number of outgrowths within the mammary gland (Table 1 footnote) . These transplant experiments demonstrate that these Int6sh transfected MCF10A cells can grow in vivo and exhibit a transformed phenotype in vitro.
In the ®rst experiments, two million cells were inoculated and only one nodule was found out of 10 implants and this was con®rmed to be of human origin. In the second set of inoculations, 10 million cells were implanted, in this experiment a signi®cant number of growths were observed for the transformed Int6sh/ MCF10A cells. Diethylstilbestrol pellets were place in ®ve recipients in each group of 15 experimental and control. This was done to promote mammary epithelial cell growth, however no signi®cant increase ) coverslips and ®xed in 3.5% paraformaldehyde. Cells were stained with a monoclonal antibody to GFP followed by a FITC-conjugated secondary antibody. DAPI was included to identify the nucleus. Images were taken utilizing standard¯uorescence microscopy ®lters on a Nikon Eclipse TE300 microscope with a 1006objective. Int6sh/CTGFP/NIH3T3 cells, one shown in (a) expressed readily detectable levels of Int6sh?GFP protein identi®ed by the green¯uorescence. The location of the stain is predominantly cytoplasmic. (b) shows the background level for auto¯uorescence in the non-expressing NIH3T3 cell transfected with vector alone Figure 4 Western blot analysis of Int6 protein expression in MCF10A cells. Lanes 1 ± 8 are from several individual stable transfectants of Int6sh/MCF10A cells. MCF10A cells were used as a negative control in the lane 9. Protein lysates (15 mg) were subjected to SDS ± PAGE and then transferred onto nitrocellulose membrane. The membrane was incubated with Int6 #20 polyclonal antibody (1 : 1000) and immunocomplexes were visualized as described in Materials and methods. Full-length Int6 protein migrates at 52.2 kDa. The blots were also reacted with Int6 #47 polyclonal antibody with identical results for Int6 wild type, however Int6sh protein was not detected although the #47 epitope is present on both Int6 wild type and Int6sh (see Figure 2) in the incidence of positive growth (2/5 with DES versus 5/10 without DES) in the Int6sh-transformed MCF10A cell implants. No in vivo growth was found at either concentration of cells or with diethylstilbestrol treatment in transplants of MCF10A cells (control) in any of these experiments. This result is consistent with published results for MCF10A cell growth in vivo (Pauley et al., 1993) .
A similar set of transplantation experiments was conducted with Int6sh-transformed HC11 cells. The transplant hosts were observed for 6 months (Table 2 ). In the ®rst experiment, Int6sh transfected HC11 cells were injected subcutaneously into the left intact #4 mammary fat pad of retired BALB/c breeders. The Figure 5 Soft agar colony analysis. Soft agar colonies were plated at a density of 30 K per well in semi-solid media, as described in Materials and methods, for MCF10A, HC11 and NIH3T3 cell lines. These soft agar cultures were incubated for 6 weeks then stained and counted. Colony numbers (at least ®ve separate samples), 50.1 mm, are plotted versus cell type. Doubly-transformed DBL/NIH3T3 cells and Harvey Ras-transformed MCF10A cells (MCF10AneoT) were provided by Dr David Salomon, LTIB, NCI as a positive control for anchorage independent growth in soft agar (Ciardiello et al., 1990a (Ciardiello et al., ,b 1992 Normanno et al., 1994) Figure 6 PCR Analysis of in vivo growths. Genomic DNA was extracted from paran embedded tissue and analysed for human Alu sequences. Mouse Cot-1 DNA (Lane 1) was used as negative control and Human Cot-1 DNA (Lane 2) as the positive control. A double-distilled H 2 O sample (Lane 3) was included to rule out contamination. Lane 4 contains DNA extracted from an epithelial growth caused by subcutaneous inoculation of Int6sh transfected MCF10A cells into the scapular fat pad of a nude mouse contralateral right intact #4 mammary fat pad was injected with non-transfected HC11 cells that served as an internal negative control. The mice were observed for 6 months for tumor growth. Thereafter, whole mounts of the mammary glands were made and examined for cellular structures distinct from endogenous structures near the lymph node injection site (Figure 7) . Groups of cells were found in three out of 16 Int6sh/HC11 implants that resembled clusters of grapes and were unlinked to the endogenous mammary ductal or alveolar structures. In the second experiment, BALB/c weanlings (ca. 21 day old) had their #4 mammary fat pads cleared of endogenous epithelium and were then injected with the 2610 6 Int6sh/HC11 cells (left #4 mammary gland) and a similar number of HC11 cells (right #4 mammary gland). Two out of the 18 mice exhibited mammary hyperplastic nodule growths from injections of Int6sh transfected HC11 cells. No epithelial nodules were seen with HC11 cells alone in either BALB/c experiment. These results demonstrate that Int6sh-transformed HC11 cells are capable of producing epithelial growths in both intact and epithelium-divested mammary fat pads whereas HC11 cells were not. It is signi®cant that Int6sh-transformed HC11 cells are able to produce growths in intact mammary glands because this is an indication of the capacity of these cells to overcome local growth regulatory control in a manner similar to premalignant mammary epithelial cells. We did not expect the nontransformed HC11 cells to grow under these conditions and they did not. In the second experiment, where the fat pads were divested of host epithelium prior to introduction of the cells, we anticipated a greater number of growth takes with an increase in the background for non-transformed HC11 growth in vivo. However, there was no positive growth of HC11 cells in these cleared fat pads. Int6sh-transformed HC11 cells however were successful in producing growths in roughly 10% of the implants.
Discussion
Integration of MMTV DNA into the mouse Int6 locus resulting in a truncation of the gene product was found in several independent mouse mammary tumors. This mutation was also present in a premalignant lesion induced by MMTV. All of these transformed mammary populations were clonal in origin suggesting that this truncating mutation to the Int6 gene was relevant to the neoplastic transformation of the aected cell. In this study, we have demonstrated that the expression of a truncated form of the Int6 gene RNA transcript in MCF10A or HC11 mammary epithelial cells and NIH3T3 embryo ®broblasts results in transformation in vitro from anchorage dependent to anchorage independent growth. Thus, the in vitro transforming activity of truncated Int6 was manifest in both epithelial and mesenchymal cells. A strong association between high steady state levels of Int6sh RNA transcript and clonal anchorage independent growth was established.
Transplantation of the Int6sh-transformed MCF10A and Int6sh transfected HC11 cells demonstrated that these cells had an increased capacity to produce epithelial growths in vivo. These data provide direct evidence that the Int6sh mutations found in MMTVinduced mouse mammary premalignant hyperplasia and in mammary tumors directly contribute to their neoplastic transformation. Notably, transformation to frank malignancy was not supported by the expression of Int6sh alone. This observation is consistent with the discovery of the mutation in a premalignant mammary lesion.
Reports have indicated that Int6 is variously associated with eukaryotic translation initiation factor, eIF3, the 43S preinitiation complex, intranuclear RNP particles and elements of the perinuclear Golgi apparatus. A recent report resolves the con¯icting literature concerning the subcellular localization of Int6/eIF3-p48 (Desbois et al., 1996; Diella et al., 1997; Neuveut et al., 1997) . Desbois et al. (1996) localized Int6 to the PML nuclear bodies, which diered from the observations of Diella et al. (1997) that placed Int6 in the Golgi region in the cytoplasm. Int6/eIF3-p48 was recently found to contain two cellular localization signals, a bipartite nuclear localization signal and a nuclear export signal (NES) (Guo and Sen, 2000) . The nuclear localization signal (NLS) is located in the midregion (amino acids 264 ± 445) of Int6/eIF3-p48 while the NES is located at the far end of the amino terminus (leucines 6, 14 and 18) ( Figure 1B) . Desbois et al. (1996) used an Int6 fusion protein containing a Flag epitope tag that replaced the ®rst eight N-terminal amino acids to determine the intracellular location of Int6. This eectively deleted the nuclear export signal from the Int6 fusion protein and explains their observation of the epitope-tagged-Int6 localized in the nucleus. The latest evidence has also identi®ed a new potential activity domain within Int6/eIF3-p48, titled the Proteasome-COP9 complex Initiation (PCI) or Proteasome-Int6-Nip1-Trip15 (PINT) motif. This suggests an interaction of Int6 with components in the proteasome/COP9 pathway (Aravind and Ponting, 1998; Hofmann and Bucher, 1998; Karniol et al., 1998; Wei and Deng, 1999) . However, to date no direct evidence supports the exact biological signi®cance of the PCI/PINT domain in the Int6 protein. These data imply Int6 may perform multiple functions in cellular processes unrelated to translation initiation. Since truncated Int6 does not contain the nuclear localization signal, we postulate that it may be more prominently eective in the cytoplasm as opposed to the nucleus and that it acts in a dominant fashion. Int6sh induces cellular changes even when two functional alleles are present in the aected cell.
Recent work upon Int6 null and Int6 wild type overexpressing Saccharamyces pombe lines correlate with our ®ndings and hypotheses. An Int6 homolog was found in ®ssion yeast (Bandyopadhyay et al., 2000; Crane et al., 2000) . The yeast Int6 protein was found strongly associated with 40S ribosomal particles suggesting a common role with mammalian Int6 in translation initiation. Deletion of Int6 from the yeast did not result in a lethal phenotype and only a moderate inhibition of global protein synthesis was observed in its absence. Polysome pro®les from the Int6 7/7 yeast indicated no defect in translation initiation. However, other phenotypes were observed, including slower growth, cell elongation and caeine sensitivity. These de®ciencies were cured by expression of wild type Int6 in the 7/7 mutants. The authors concluded that Int6 was not essential for translation initiation in ®ssion yeast. Notably, introduction of human Int6 (identical to the mouse gene) suppressed the slower growth of the Int6 gene-deleted yeast, but did not relieve the other phenotypes. Therefore mammalian Int6 is at least partially functional in yeast. In addition, expression of yeast Int6, with a Cterminus truncation of 50 amino acids, in the wild type cells resulted in increased caeine sensitivity similar but more severe than that observed in the gene-deleted strain. The authors postulate that Int6 may be required for translation of a speci®c set of proteins that eect membrane structure and function, the absence or reduction of these might result in aberrant membrane functions such as endocytosis or transmission of intercellular signals.
Int6sh displays a transformed phenotype similar to that seen in the oncogenic properties of other truncated proteins. The High Mobility Group I (splice variant C) protein (HMGI-C) proteins belong to a group of DNA-binding proteins, which are abundant, heterogeneous, nonhistone components of chromatin (Grosschedl et al., 1994) . HMGI-C genes often contain C-terminal truncations that induce neoplastic transformation of NIH3T3 murine ®broblasts (Fedele et al., 1998) . HMGI-C truncations and chimeras have transforming activity on NIH3T3 ®broblasts, are able to grow in soft agar, and to induce tumors when inoculated into athymic mice. Fedele et al. (1998) postulate that HMGI-C truncations interfere in a dominant fashion with the activity of those transcription factors that are dependent upon HMGI-C thereby inducing transformation. Another example of neoplastic transformation by truncation is with Notch-1. Notch-1 truncations are associated with transformation in Moloney MuLV-infected MMTV D /myc transgenic mice (Girard and Jolicoeur, 1998) . Several tumors, containing a Notch1 rearrangement, over expressed full length Notch1 RNA and protein. However, full length Notch1 was eventually not directly involved in transformation of tumors harboring a provirally activated truncated Notch1 allele.
HC11 cells, which are transformed to anchorageindependent growth by Int6sh, do not possess a functional wild type p53 allele. Nonetheless, Int6sh-transformed HC11 cells did not form tumors when injected into immune-compromised hosts. In mouse mammary tumors, the Int6 gene promoter drives expression of the shortened Int6 allele. We have no information regarding the transcriptional control of Int6, however it appears to be constitutive in noncycling tissue. In the HOG and tumors, the Int6sh transcript ends in the MMTV LTR promoter but in our system no MMTV sequences are present, suggesting that there may be no contribution of the MMTV sequences to the transforming activity of truncated Int6. Marchetti et al. (2001) recently published a study, which investigated the frequency of Int6 mutations in human breast and lung carcinomas. They cited evidence for a concomitant reduction of Int6/eIF3-p48 expression in a subset of human breast and lung carcinomas. In addition, a relationship was established between decreased expression of Int6/eIF3-p48 and tumor histotype in non-small cell lung carcinomas, which are almost exclusively adenocarcinomas. Thus, it is tempting to postulate that loss of normal Int6/eIFp48 deregulates a critical cellular pathway (translation and/or proteasome) and leads to neoplastic transformation. However, additional work is needed to elucidate the pathways that are directly aected by perturbation of Int6/eIF3-p48 expression and induction of neoplastic transformation.
In conclusion, we have taken a ®rst step toward demonstrating that expression of a truncated form of the Int6 gene transcript may result in partial transformation of the aected cell. Our longer-term approach to this question has resulted in the creation of a transgenic mouse model where Int6sh is expressed in the mammary glands from the mouse Whey Acidic Protein (WAP) promoter. Presently we have developed 11 independent founder lines but have only found expression of the transgene in the lactating mammary tissue of two of these families. We are currently forcebreeding females from these expressing lines to determine whether hyperplasia or tumors will appear in the aected mammary tissues. Of interest is a male founder line where two of the F1 sibling males have developed testicular masses and have failed to breed successfully. A 1995 study of WAP promoter expression in male mice indicates that WAP is expressed constitutively in the testes, however the precise cellular locale of WAP expression within the testis has not been ascertained (Wen et al., 1995) . We are currently determining if these testicular lesions are associated with the expression of the transgene.
Materials and methods

Antibodies
As described previously , polyclonal antibodies against the synthetic peptides #20 (KDVRKRRQVLKDLVKVIQQE) and #47 (YKNLYSD-DIPHLREK) of Int6 were used in immunoprecipitation and Western immunoblot. The epitope of antibody #47 (Int6 #47) is located at the N-terminus of Int6 while antibody #20's epitope is found towards the Int6 C-terminus. Thus, Int6 #20 antibody does not recognize the Int6sh protein (see Figure 1) . In addition, commercially available monoclonal and polyclonal HA.11 (Babco/Covance, Berkley, CA, USA) against hemagluttinin were also used in Western immunoblots.
Enzymes
All restriction endonucleases were purchased from Boehringer Mannheim (Indianapolis, IN, USA) or Promega (Madison, WI, USA) and used according to manufacturer's speci®cations.
Oligonucleotides
All DNA oligomers were purchased from either IDT (Coraville, IA, USA) or Life Technologies (Gaithersburg, MD, USA).
DNA preparation
All DNA plasmid preparations were performed according to the established protocols by Sambrook et al. (1989) Plasmid preparations were facilitated through the use of either the Wizard TM miniprep DNA puri®cation system, a commercial kit from Promega (Madison, WI, USA) or Qiaprep TM miniprep DNA puri®cation system, a commercial kit from Qiagen, Inc (Chatsworth, CA, USA). DNA used for transfection was puri®ed using standard CsCl techniques by Lofstrand Labs Inc (Gaithersburg, MD, USA). DNA fragment preparations were simpli®ed through the used of the Qiaex II Gel Extraction Kit, a commercial kit from Qiagen Inc. (Chatsworth, CA, USA).
Recombinant Int6sh gene construction
Two oligonucleotides of approximately 30 bp were used along with Int6 cDNA from murine cell lines to amplify a 700 bp region using the polymerase chain reaction (PCR). Forward primer was DG621 ± 5'-GGT-AAG-CTT-AAC-AAG-CGC-TCC-TTT-CCC-CC-3' and Int6SHREV ± 5'-GGA-CTT-AAG-GAA-GCC-AGA-GTC-TTG-GGT-TGC-3'. This process generated a synthetic Int6sh gene with¯anking HindIII and EcoRI restriction endonuclease sites. Recombinant Int6sh gene was initially identi®ed by restriction analysis. The DNA sequence of the synthetic Int6sh gene was determined and the correct nucleotide sequences con®rmed. This HindIII ± EcoRI Int6sh DNA fragment was ligated directly into the pCEFLHA vector.
C-terminal green fluorescent protein construction
The Int6sh gene cassette was ampli®ed from Int6sh-pCEFLHA vector using two primers of approximately 20 bp. Int6Start_For ± 5'-TCC-CCC-GGC-AAG-ATG-GCG-G-3'; HA1_Rev ± 5'-CGT-AAT-CCG-GTA-CGT-CAT-3'. This synthetic Int6sh-HA PCR product was then ligated to the pCDNA3.1/CT-GFP-TOPO vector according to manufacturer's protocol.
Ligation and transformation reactions
Ligation and transformation reactions were done according to published procedures in Sambrook et al. (1989) The only deviation from published procedure was done according to the recommended protocol provided by the manufacturer regarding the particular bacterial host and commercial source of T 4 DNA Ligase.
PCR analysis for Alu sequences
Genomic DNA was extracted from tissue using Qiagen's QiAmp Kit as per protocol for paran embedded tissue. The primer set used for Alu sequences was SBR13 (For), 5'-GCCTGTAATCCCAGCACTTT-3' and SBR14 (Rev), 5'-CCGGGTTCACGCCATTC-3'. Annealing temperature was 598C with a product of 188 bp. Utilized Easystart TM 100 PCR Mix in a Tube (Molecular BioProducts, San Diego, CA, USA). Mouse Cot-1 DNA (Gibco ± BRL) was used as negative control and Human Cot-1 DNA (Gibco ± BRL) was used as the positive control.
Expression plasmids
The synthetic Int6short gene was ligated into the pCEFLHA vector (Omar Coso) and transformed into DH5a cells (Gibco ± BRL, Gaithersburg, MD, USA). DNA sequences were veri®ed using dye terminator sequencing on an ALF automated sequencer. The pCEFLHA transfection vector has the backbone of pCDNA # 3.0(+) (Invitrogen, Carlsbad, CA, USA) with several modi®cations. The cytomegalovirus (CMV) promoter was replaced by eukaryotic elongation factor-1 alpha promoter (eEF1A). The multiple cloning site was altered to accommodate the HA epitope tag. This vector contains the Neo R gene that allows selection of stable transfectants using G418 sulfate. This vector was obtained from Dr Omar Coso. To express truncated Int6, a vector was constructed from the pCDNA 3.1(+) backbone, replacing the cytomegalovirus (CMV) promoter with elongation factor 1-alpha (eEF1A) promoter and adding a hemagluttinin (HA) epitope tag for protein identi®cation purposes. This promoter has previously been used to drive expression of genes in a wide range of cell types in vitro (Goldman et al., 1996; Mizushima and Nagata, 1990) .
For the C-terminal green¯uorescent fusion protein, the pCDNA3.1/CT-GFP-TOPO vector (Invitrogen, Carlsbad, CA, USA) was utilized to ligate the synthetic Int6sh-HA PCR product. This vector also contains the Neo R and Amp R gene. . The antibody-protein G-agarose pellet was washed as per manufacturer's protocol and eluted into 50 microliters of 16SDS ± PAGE loading dye for direct loading upon an SDS ± PAGE gel.
Cell lines and culture conditions
MCF-10A cells (Soule et al., 1990) , a normal human mammary epithelial cell line, were cultured in DMEM/F-12 (1 : 1) supplemented with 5% equine serum (heat inactivated; Gemini BioProducts, Calabassas, CA, USA), 2 mM glutamine (Gibco ± BRL, Gaithersburg, MD, USA), 20 mM HEPES (Gibco ± BRL), 100 ng/ml of cholera toxin (List Biological Laboratories, Campbell, CA, USA), 10 mg/ml of insulin (Gibco ± BRL), 500 ng/ml of hydrocortisone (Sigma Chemical Co., St. Louis, MO, USA), and 10 ng/ml of recombinant mouse EGF (Collaborative Biomedical Products, Bedford, MA, USA). Cells are grown in 5% CO 2 at 378C. HC11 cells, a normal mouse mammary epithelial cell line, were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (heat inactivated; Gemini BioProducts), 2 mM glutamine, 5 mg/ml of insulin, and 10 ng/ml of recombinant mouse EGF. NIH3T3 cells, a normal mouse embryo ®broblast cell line, were cultured in DMEM supplemented with 10% fetal bovine serum (heat inactivated; Gemini BioProducts). All cell lines are routinely passaged in media containing penicillin-streptomycin at a ®nal concentration of 16(Gibco ± BRL). Cell lines that were selected for Neomycin resistance were initially culture in 750 mg/ml Neomycin sulphate until stable lines were created. Afterwards, these cell lines were maintained in 350 mg/ml Neomycin sulphate. Doubly-transformed DBL/NIH3T3 cells and Harvey Ras-transformed MCF10A cells (MCF10AneoT) were provided by Dr David Salomon, LTIB, NCI as a positive control for anchorage independent growth in soft agar (Ciardiello et al., 1990a (Ciardiello et al., ,b, 1992 Normanno et al., 1994) These transformed cell lines were cultured in conditions identical to that of their originating cell lines, NIH3T3 and MCF10A respectively.
Immunocytochemistry
Int6sh-CTGFP/NIH3T3 cells were seeded onto 22 mm square glass cover slips in a six-well plate and cultured in DMEM supplemented with 10% FBS. All steps were performed at room temperature unless noted otherwise. After washing twice in PBS, cells were ®xed with 3.5% paraformaldehyde in PBS for 10 min and then permeabilized with 0.5% Triton X-100 in PBS for 10 min. The wash solution contained 0.1% Tween 20 and 10% FBS in PBS. Cells were then washed once and then incubated with a 1 : 1000 dilution of monoclonal GFP antibody (Covance), diluted in wash solution, for 3 h. Coverslips were then washed once and then incubated with goal anti mouse FITC conjugated secondary antibody (1 : 250, Santa Cruz Biotechnology, Santa Cruz, CA, USA) containing DAPI (1 : 50 000, Molecular Probes) in wash solution for 2 h. Coverslips were then washed twice and then rinsed twice in distilled water. Coverslips were mounted onto standard microscope slides using Prolong Antifade mounting media (Molecular Probes). Cells were visualized using a standard Nikon Eclipse TE300 microscope and 1006objective with 5000 ms exposure. Filter set used was 403/460 nm for DAPI and 492/520 nm for FITC.
Soft agar growth assay
A stock solution of 2.7% SeaKem GTG agar in ddH 2 O was prepared and autoclaved for 20 min. Agar was then cooled in a 658C bath. For the base layer, the agar stock solution was mixed with medium to reach a ®nal concentration of 0.9% and allocated at 1 ml/35 mm dish. The base layer was allowed to cool and solidify for 30 min. A top agar containing 0.34% agar was prepared in a similar manner, with cells added to the top agar at a ®nal concentration of either 15 000 or 30 000 cells/ml/dish. Two ml of this mixture was layered on top of the base layer and allowed to solidify for 30 min ± 1 h before placing dishes into a 378C, 5% CO 2 incubator. Plates were grown for 3 ± 4 weeks or until colonies were apparent. The day before counting colonies, stain with 1 ml/well of nitrobluetetrazolium (50 mg NBT in 100 ml PBS). Colonies were counted using an Artek camera system.
Cell lysis and fractionation protocol
Cells, at 80 ± 90% con¯uence in a 75 cm 3¯a sk, were washed twice in cold PBS. Then, 1 ml of lysis buer (50 mm Tris, pH 7.5, 2 mm EDTA, 1% Triton X-100, 100 mm NaCl) was added to the cells, and the cells were subsequently scraped into solution using a plastic cell lifter (Costar 1 Corp., Cambridge, MA, USA). This mixture was then mixed in equal amounts with 26SDS loading buer and analysed by denaturing SDS ± PAGE electrophoresis.
Sodium dodecyl sulfate polyacrylamide gels (SDS ± PAGE)
All SDS ± PAGE gels were purchased from either Novex (San Diego, CA, USA) or BioRAD (Hercules, CA, USA) and electrophoresed according to the protocols listed in Sambrook et al. (1989) . The protein gels used a Tris-Glycine buering system.
Western immunoblot analysis
Western immunoblot detection of Int6 protein followed the procedure of Towbin et al. (1979) A polyclonal antiserum against the Int6 #20 peptide was used as the primary antibody. Sheep anti-rabbit IgG antiserum conjugated to horseradish peroxidase (Amersham, Arlington Heights, IL, USA) was used as the secondary antibody. Immunoblots were developed using chemiluminescent reagents provided in the ECL kit also from Amersham. Bands were visualized using autoradiographic ®lm at varying exposure times.
Protein concentration determination
Protein concentrations were determined using the BioRAD Protein Assay kit (BioRAD, Hercules, CA, USA). Serial dilutions of bovine plasma gamma globulin (BioRAD standard I) were used as a protein standard.
In vivo experiments
In vivo experiments were done to assess the tumorigenic potential of Int6sh transfected MCF10A cell lines. In the ®rst experiment, two methods were used for introduction of the transfected cells in vivo (2610 6 cells/10 ml injection in PBS). One-year-old athymic (nu/nu) mice were subcutaneously injected directly into the L4 mouse mammary fat pad distal to the lymph node; 30 mice were utilized for experimental cells (three dierent clones) and 10 for the control group (MCF10A). The second method involved an intrascapular injection of a 1 : 1 mixture of Int6sh/MCF10A cells and Matrigel
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. Ten mice per experimental group were used (three independent clones of Int6sh/MCF10A and one control MCF10A group).
Based on the ®rst experiment, a second in vivo experiment was performed with athymic mice. The mice were injected subcutaneously near the #4 mammary nipple with a 1 : 1 mixture of cells and Matrigel A third in vivo experiment was performed using Int6sh/ HC11 cells. First, injections were done into the L4 mammary fat pads of BALB/c mice, whose ages were at least 12 months or more; the contralateral R4 mammary fat pad was injected with HC11 cells, which are serving as an internal negative control. Each injection contained 2610 6 cells in 100 ml of media. Second, BALB/c weanlings had their #4 mammary fat pads cleared and then injected in the same fashion as listed above for the yearlings.
